Clinical markers associated with glycaemic response to dipeptidyl peptidase-4 inhibitor therapy

被引：2
|
作者：
Yamagishi, Sho-ichi [1 ]
机构：
[1] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷 / 07期
关键词：
advanced glycation end products; DPP-4; insulin resistance; oxidative stress; GLYCATION END-PRODUCTS; DPP-4; OBESITY; GLP-1;
D O I：
10.1002/dmrr.3024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
    Larry K. Golightly
    Caitlin C. Drayna
    Michael T. McDermott
    Clinical Pharmacokinetics, 2012, 51 (8) : 501 - 514
  • [22] C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy
    Demir, Sevin
    Temizkan, Sule
    Sargin, Mehmet
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [23] Dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid
    Reactions Weekly, 2021, 1861 (1) : 9 - 9
  • [24] Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans
    Ahren, B.
    Schweizer, A.
    Dejager, S.
    Villhauer, E. B.
    Dunning, B. E.
    Foley, J. E.
    DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 775 - 783
  • [25] Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
    Golightly, Larry K.
    Drayna, Caitlin C.
    McDermott, Michael T.
    CLINICAL PHARMACOKINETICS, 2012, 51 (08) : 501 - 514
  • [26] Dipeptidyl peptidase-4 inhibitors -: Clinical data and clinical implications
    Ahren, Bo
    DIABETES CARE, 2007, 30 (06) : 1344 - 1350
  • [27] Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes
    Lajara, Rosemarie
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (18) : 2663 - 2671
  • [28] Dipeptidyl peptidase-4 inhibitor-related renal disease
    Suenaga, Atsuhiko
    Sawa, Naoki
    Oba, Yuki
    Ikuma, Daisuke
    Sekine, Akinari
    Hasegawa, Eiko
    Mizuno, Hiroki
    Suwabe, Tatsuya
    Ikeda, Sara
    Tsujimoto, Tetsuro
    Kono, Kei
    Shintani-Domoto, Yukako
    Kinowaki, Keiichi
    Ohashi, Kenichi
    Miyazono, Motoaki
    Yamaguchi, Yutaka
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (10)
  • [29] Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS Database
    Nagel, Angela K.
    Ahmed-Sarwar, Nabila
    Werner, Paul M.
    Cipriano, Gabriela C.
    Van Manen, Robbert P.
    Brown, Jack E.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (01) : 27 - 31
  • [30] Renoprotective Effect of a Dipeptidyl Peptidase-4 Inhibitor on Aging Mice
    Ban, Tae H.
    Kim, Eun N.
    Kim, Min Y.
    Lim, Ji H.
    Lee, Jong H.
    Kim, Hyung D.
    Yoon, Hye E.
    Park, Cheol W.
    Choi, Bum S.
    AGING AND DISEASE, 2020, 11 (03): : 588 - 602
12345